MN
Mohammad Naieem Mattoo
About Mohammad Naieem Mattoo
Data last updated:
Mohammad Naieem Mattoo has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Solicitous Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Solicitous Pharmaceuticals Private Limited at ₹3.92 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Solicitous Pharmaceuticals Private Limited U85100DL2013PTC262658 | Director | 06 May 2015 | 2013 | ₹3.92 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammad Naieem Mattoo
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammad Naieem Mattoo
Mohammad Naieem Mattoo has 11 years in corporate governance. Holds Director role. Currently with 1 company, including Solicitous Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Solicitous Pharmaceuticals Private Limited at ₹3.92 Cr (FY 2025).
Mohammad Naieem Mattoo is associated with 1 company as Director, including Solicitous Pharmaceuticals Private Limited (₹3.92 Cr).
Mohammad Naieem Mattoo has expertise in General Business.
Mohammad Naieem Mattoo has 11 years in corporate governance.
By reported revenue, the largest current company of Mohammad Naieem Mattoo is Solicitous Pharmaceuticals Private Limited, with revenue of ₹3.92 Cr (FY 2025).
Mohammad Naieem Mattoo currently holds positions at 1 company: Solicitous Pharmaceuticals Private Limited (₹3.92 Cr).